Episode

From Mammoths to Humans: The Case for Gene Editing with Eriona Hysolli

Podcast
Modern CTO
Published
Jun 1, 2026
Duration seconds
3149
Processing state
not_requested
Canonical source
https://chrt.fm/track/B4A277/traffic.megaphone.fm/LDB8050524169.mp3
Audio
https://chrt.fm/track/B4A277/traffic.megaphone.fm/LDB8050524169.mp3
JSON
/v1/public/podcasts/modern-cto-509977/episodes/from-mammoths-to-humans-the-case-for-gene-editing-with-eriona-hysolli
Markdown
/podcast/modern-cto-509977/from-mammoths-to-humans-the-case-for-gene-editing-with-eriona-hysolli.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/modern-cto-509977/episodes/from-mammoths-to-humans-the-case-for-gene-editing-with-eriona-hysolli/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/modern-cto-509977/from-mammoths-to-humans-the-case-for-gene-editing-with-eriona-hysolli.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Can today’s technology really prevent tomorrow’s diseases? Today, we're talking to Eriona Hysolli, biologist and co-founder of Manhattan Genomics. We discuss why preventing genetic disease before birth is a more powerful idea than treating it in adulthood, how the UK quietly pioneered a procedure that most of the world still considers off-limits, why the loudest opposition to gene editing often comes from bioethicists rather than the public, and what it would actually take to engineer traits — from woolly mouse hair to human limb regeneration — with enough certainty to act on. To learn more about Eriona, connect with her on LinkedIn.